By using this website you agree that we use cookies. You can find out more in the privacy policy.

Arizona Tribune - Moderna to Present at the 44th Annual J.P. Morgan Healthcare Conference

Arizona Tribune
×
NYSE - LSE
SCS 0.12% 16.14 $
RIO -4.5% 91.03 $
CMSC 0.21% 23.76 $
BCE 1.43% 25.86 $
RBGPF 1.65% 83.78 $
BTI 0.76% 60.68 $
BCC 0.63% 80.81 $
CMSD -0.17% 24.05 $
NGG 0.23% 85.27 $
GSK 1.82% 51.6 $
JRI 1.07% 13.08 $
AZN 0.19% 92.77 $
RELX -1.03% 35.8 $
BP -0.42% 37.88 $
RYCEF -2.69% 16 $
VOD -0.41% 14.65 $
Moderna to Present at the 44th Annual J.P. Morgan Healthcare Conference
Moderna to Present at the 44th Annual J.P. Morgan Healthcare Conference

Moderna to Present at the 44th Annual J.P. Morgan Healthcare Conference

BOULEVARD 17.12.2025

CAMBRIDGE, MA / ACCESS Newswire / December 17, 2025 / Moderna, Inc. (Nasdaq:MRNA) today announced it will present at the 44th annual J.P. Morgan Healthcare Conference on Monday, January 12th at 7:30 p.m. ET / 4:30 p.m. PT.

Text size:

A live webcast of the presentation will be available under "Events and Presentations" in the Investors section of the Moderna website at investors.modernatx.com.

A replay of the webcast will be archived on Moderna's website for at least 30 days following the presentation.

About Moderna

Moderna is a pioneer and leader in the field of mRNA medicine. Through the advancement of its technology platform, Moderna is reimagining how medicines are made to transform how we treat and prevent diseases. Since its founding, Moderna's mRNA platform has enabled the development of vaccines and therapeutics across infectious diseases, cancer, rare diseases and more.

With a global team and a unique culture, driven by the company's values and mindsets, Moderna's mission is to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X, Facebook, Instagram, YouTube and LinkedIn.

Investors:
Lavina Talukdar
Senior Vice President & Head of Investor Relations
617-209-5834
[email protected]

SOURCE: Moderna, Inc.



View the original press release on ACCESS Newswire

N.Mitchell--AT

Featured

Death toll from Swiss New Year bar fire rises to 41

Death toll from Swiss New Year bar fire rises to 41
Pakistan combing for perpetrators after deadly separatist attacks

Pakistan combing for perpetrators after deadly separatist attacks
Exiled Tibetans choose leaders for lost homeland

Exiled Tibetans choose leaders for lost homeland
Deportation raids drive Minneapolis immigrant family into hiding

Deportation raids drive Minneapolis immigrant family into hiding